Abstract
The use of psychotropic medications in youth with emotional disturbances in state custody is increasing and presents unique challenges concerning consent and oversight. We examine various means that state child welfare agencies use to provide consent for and oversight of psychotropic medications for children in state custody and describe benefits of a consent process that provides for expert consultation to the child welfare agency and prescribing clinicians, case-specific and systemic oversight of psychotropic medication use, and education for stakeholders.
MeSH terms
-
Adolescent
-
Affective Symptoms / diagnosis
-
Affective Symptoms / drug therapy*
-
Affective Symptoms / psychology
-
Case Management / legislation & jurisprudence*
-
Child
-
Child Behavior Disorders / diagnosis
-
Child Behavior Disorders / drug therapy*
-
Child Behavior Disorders / psychology
-
Child Custody / legislation & jurisprudence*
-
Child Welfare / psychology*
-
Drug Approval / legislation & jurisprudence
-
Expert Testimony / legislation & jurisprudence
-
Health Policy / legislation & jurisprudence
-
Humans
-
Informed Consent / legislation & jurisprudence*
-
Psychotropic Drugs / therapeutic use*
-
Referral and Consultation / legislation & jurisprudence
-
Stress Disorders, Post-Traumatic / diagnosis
-
Stress Disorders, Post-Traumatic / drug therapy*
-
Stress Disorders, Post-Traumatic / psychology
-
Third-Party Consent / legislation & jurisprudence*
-
United States